Epstein Secrets

e basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and includes the cash proceeds received from the Se

companies). The study concluded that companies with stocks listed on national exchanges had lower discounts than companies with stocks traded OTC. • Gelman Study's. The Gelman Study reviewed the prices paid by four closed-end investment companies specializing in restricted securities from 1968 to 1970. This stu

e basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and includes the cash proceeds received from the Se

companies). The study concluded that companies with stocks listed on national exchanges had lower discounts than companies with stocks traded OTC. • Gelman Study's. The Gelman Study reviewed the prices paid by four closed-end investment companies specializing in restricted securities from 1968 to 1970. This stu

e basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and includes the cash proceeds received from the Se

companies). The study concluded that companies with stocks listed on national exchanges had lower discounts than companies with stocks traded OTC. • Gelman Study's. The Gelman Study reviewed the prices paid by four closed-end investment companies specializing in restricted securities from 1968 to 1970. This stu